Fusion Pharmaceuticals Overview

Fusion Pharmaceuticals Other Income Expense Net

Other Income/Expense Net for FUSN.

Quarterly Other Income/Expense

$1.95M

↑ 253.16% YoY

As of Mar 31, 2024

Annual Other Income/Expense (TTM)

$5.31M

↑ 860.04% YoY

Trailing 12 months ending Mar 31, 2024

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin